Showing results (161-170 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|November 20, 2020
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ InhibitorsDillon H Miles, Xuelei Yan, Rhiannon Thomas-Tran, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Structural Basis for Activation of Human Sirtuin 6 by FluvastatinWeijie You, Clemens Steegborn
ACS Medicinal Chemistry Letters|November 20, 2020
Novel Betulinic Acid-Nucleoside Hybrids with Potent Anti-HIV ActivityQiang Wang, Yujiang Li, Liyun Zheng, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio choleraeFrancesca Mancuso, Laura De Luca, Andrea Angeli, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Improved Synthesis of [11C]COU and [11C]PHXY, Evaluation of Neurotoxicity, and Imaging of MAOs in Rodent HeartAllen F Brooks, Anthony J Mufarreh, Xia Shao, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 EntryHongguang Ma, Huiqun Wang, Mengchu Li, et al.
ACS Medicinal Chemistry Letters|September 17, 2020
Understanding and Improving the Membrane Permeability of VH032-Based PROTACsVictoria G Klein, Chad E Townsend, Andrea Testa, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell KillingTimothy A Lewis, Luc de Waal, Xiaoyun Wu, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic FibrosisMarc J C Scanio, Xenia B Searle, Bo Liu, et al.
ACS Medicinal Chemistry Letters|November 22, 2019
Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR InhibitorsDries J H De Clercq, David E Heppner, Ciric To, et al.
Pageof 438